These were not false-positives suspicious results that turn out upon further testing not to be cancer. These were indeed cancerous tumors, but ones that caused no symptoms and were unlikely ever to become deadly, the researchers said.
Still, the results are not likely to change how doctors treat lung cancer.
For one thing, the disease is usually diagnosed after symptoms develop, when tumors show up on an ordinary chest X-ray and are potentially life-threatening.
The findings underscore the need to identify biological markers that would help doctors determine which tumors are harmless and which ones require treatment, said Dr Edward Patz, Jr lead author and a radiologist at Duke University Medical Center. He is among researchers working to do just that.
A leader of an influential government-appointed health panel agreed.
"Putting the word 'harmless' next to cancer is such a foreign concept to people," said Dr Michael LeFevre, co-chairman of the US Preventive Services Task Force.
A final recommendation is pending, but LeFevre said the panel had already assumed that screening might lead to overdiagnosis.
"The more we bring public awareness of this, then the more informed decisions might be when people decide to screen or not," LeFevre said.
He called the study "a very important contribution," but said doctors will face a challenge in trying to explain the results to patients.
The study was published yesterday in the journal JAMA Internal Medicine.
The new study is an analysis of data from the National Lung Cancer Screening Trial National Cancer Institute research involving 53,452 Americans at high risk for lung cancer who were followed for about six years.
Half of them got three annual low-dose CT scans a type of X-ray that is much more sensitive than the ordinary variety and half got three annual conventional chest X-rays.
During six years of follow-up, 1,089 lung cancers were diagnosed in CT scan patients, versus 969 in those who got chest X-rays.
That would suggest CT scans are finding many early cases of lung cancer that may never advance to the point where they could be spotted on an ordinary chest X-ray.
The new analysis suggests that for every 10 lives saved by CT lung cancer screening, almost 14 people will have been diagnosed with a lung cancer that would never have caused any harm, said Dr Len Lichtenfeld, the cancer society's deputy chief medical officer.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
